首页> 外文期刊>军事医学研究:英文版 >The origin, transmission and clinical therapies on coronavirus disease 2019(COVID-19) outbreak——an update on the status
【24h】

The origin, transmission and clinical therapies on coronavirus disease 2019(COVID-19) outbreak——an update on the status

机译:2019年冠状病毒疾病的起源,传播和临床疗法(Covid-19)爆发 - 了解情况的更新

获取原文
获取原文并翻译 | 示例
           

摘要

An acute respiratory disease,caused by a novel coronavirus(SARS-CoV-2,previously known as 2019-nCoV),the coronavirus disease 2019(COVID-19)has spread throughout China and received worldwide attention.On 30 January 2020,World Health Organization(WHO)officially declared the COVID-19 epidemic as a public health emergency of international concern.The emergence of SARS-CoV-2,since the severe acute respiratory syndrome coronavirus(SARSCoV)in 2002 and Middle East respiratory syndrome coronavirus(MERS-CoV)in 2012,marked the third introduction of a highly pathogenic and large-scale epidemic coronavirus into the human population in the twenty-first century.As of 1 March 2020,a total of 87,137 confirmed cases globally,79,968 confirmed in China and 7169 outside of China,with 2977 deaths(3.4%)had been reported by WHO.Meanwhile,several independent research groups have identified that SARS-CoV-2 belongs toβ-coronavirus,with highly identical genome to bat coronavirus,pointing to bat as the natural host.The novel coronavirus uses the same receptor,angiotensin-converting enzyme 2(ACE2)as that for SARS-CoV,and mainly spreads through the respiratory tract.Importantly,increasingly evidence showed sustained human-tohuman transmission,along with many exported cases across the globe.The clinical symptoms of COVID-19 patients include fever,cough,fatigue and a small population of patients appeared gastrointestinal infection symptoms.The elderly and people with underlying diseases are susceptible to infection and prone to serious outcomes,which may be associated with acute respiratory distress syndrome(ARDS)and cytokine storm.Currently,there are few specific antiviral strategies,but several potent candidates of antivirals and repurposed drugs are under urgent investigation.In this review,we summarized the latest research progress of the epidemiology,pathogenesis,and clinical characteristics of COVID-19,and discussed the current treatment and scientific advancements to combat the epidemic novel coronavirus.
机译:由新型冠状病毒(SARS-COV-2,以前称为2019-NCOV)引起的急性呼吸系统疾病,2019年冠状病毒疾病(Covid-19)在整个中国传播,并在全球范围内接受。2020年1月30日,世界卫生组织(世卫组织)正式宣布Covid-19作为国际问题的公共卫生紧急情况。SARS-COV-2的出现,自2002年的严重急性呼吸综合征Coronavirus(SARSCOV)和中东呼吸综合征冠状病毒(MERS- COV)在2012年,标志着,在二十一世纪的三世纪第三次引入了高致病和大规模的流行病毒.2020年3月1日,全球共有87,137例确诊,79,968人确认,7169在中国以外,曾举行过2977岁的死亡(3.4%)。何时举行,若干独立的研究小组已经确定了SARS-COV-2属于Toβ-coronavirus,具有高度相同的基因组到蝙蝠冠状病毒,指向蝙蝠作为自然的蝙蝠h T.新型冠状病毒使用相同的受体,血管紧张素转换酶2(ACE2),因为对于SARS-COV,主要通过呼吸道传播。常剧,越来越多的证据表明持续的人类 - 托管传输,以及许多出口案件全球Covid-19患者的临床症状包括发烧,咳嗽,疲劳和患者患者的胃肠道感染症状。患有潜在疾病的老年人和人群易感染,容易出现严重的成果,这可能与急性呼吸窘迫综合征(ARDS)和Cytokine Storm.CRIVELLITE,有很少的特定抗病毒力策略,但若干有效的抗病患者和重新审查的药物都在紧急调查中。在审查中,我们总结了流行病学,发病机制的最新研究进展, Covid-19的临床特征,并讨论了当前的处理和科学进步,对抗流行病Nove l冠状病毒。

著录项

  • 来源
    《军事医学研究:英文版》 |2020年第1期|P.93-103|共11页
  • 作者单位

    Guangdong Provincial Key Laboratory of Biomedical Imaging and Guangdong Provincial Engineering Research Center of Molecular Imaging Zhuhai 519000 Guangdong China;

    Department of Cardiothoracic Surgery the Fifth Affiliated Hospital Sun Yat-Sen University Zhuhai 519000 Guangdong China;

    Center of Infectious Disease the Fifth Affiliated Hospital Sun Yat-Sen University Zhuhai 519000 Guangdong China;

    Guangdong Provincial Key Laboratory of Biomedical Imaging and Guangdong Provincial Engineering Research Center of Molecular Imaging Zhuhai 519000 Guangdong China;

    Guangdong Provincial Key Laboratory of Biomedical Imaging and Guangdong Provincial Engineering Research Center of Molecular Imaging Zhuhai 519000 Guangdong China;

    Guangdong Provincial Key Laboratory of Biomedical Imaging and Guangdong Provincial Engineering Research Center of Molecular Imaging Zhuhai 519000 Guangdong China;

    Department of Otolaryngology Yong Loo Lin School of Medicine National University of Singapore National University Health System Singapore 119228 Singapore;

    Department of Otolaryngology Yong Loo Lin School of Medicine National University of Singapore National University Health System Singapore 119228 Singapore;

    Guangdong Provincial Key Laboratory of Biomedical Imaging and Guangdong Provincial Engineering Research Center of Molecular Imaging Zhuhai 519000 Guangdong ChinaCenter for Interventional Medicine the Fifth Affiliated Hospital Sun Yat-Sen University Zhuhai 519000 Guangdong China;

  • 收录信息 中国科学引文数据库(CSCD);
  • 原文格式 PDF
  • 正文语种 chi
  • 中图分类 肺炎;
  • 关键词

    Clinical characteristics; Coronavirus disease 2019(COVID-19); Origin; SARS-CoV-2; Therapy; Transmission;

    机译:临床特征;冠状病毒疾病2019(Covid-19);起源;SARS-COV-2;治疗;传输;
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号